IP Verse

Boehringer Ingelheim Pharma Boehringer Ingelheim competitive analysis

Loading summary...

Latest oppositions filed by Boehringer Ingelheim Pharma Boehringer Ingelheim

Explore patent oppositions filed by Boehringer Ingelheim Pharma Boehringer Ingelheim against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 23, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP2634243
Improved Process For The Culturing Of CellsDPXJun 5, 2018
EP2634242
Improved Process For The Culturing Of CellsDPXJan 4, 2018
EP2634250
Improved Process For The Culturing Of CellsDPXJan 4, 2018

Latest publications and patents of Boehringer Ingelheim Pharma Boehringer Ingelheim New

Explore the latest publications and patents granted to Boehringer Ingelheim Pharma Boehringer Ingelheim, showcasing their recent innovations and technological advancements.

Latest PTAB cases involving Boehringer Ingelheim Pharma Boehringer Ingelheim

Discover the latest PTAB cases involving Boehringer Ingelheim Pharma Boehringer Ingelheim, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Boehringer Ingelheim Pharma Boehringer Ingelheim with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
BOEHRINGER INGELHEIM PHARMA BOEHRINGER INGELHEIM3 - - -
DPX - 9 - -
DSM ASSETS1995 - 15
PATHEON I - 9 - -